Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-16 Tax Withholding | 2022-05-18 7:19 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 832 | $5.67 | 121,110 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 4:06 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 9,072 | $0 | 873,080 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 4:06 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 9,072 | $2.48 | 873,080 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-01 8:00 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 15,625 | $0 | 873,080 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-01 8:00 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 15,625 | $2.48 | 873,080 (Direct) | View |
| 2022-02-04 Tax Withholding | 2022-02-08 9:09 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 981 | $11.4 | 873,080 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 9:09 pm | N/A 2032-02-04 | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 122,673 | $0 | 873,080 (Direct) | View |
| 2022-01-31 Exercise | 2022-02-02 8:11 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 15,625 | $0 | 751,388 (Direct) | View |
| 2022-01-31 Exercise | 2022-02-02 8:11 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 15,625 | $2.48 | 751,388 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 8:48 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 40,322 | $2.47 | 750,000 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 8:48 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 40,322 | $0 | 750,000 (Direct) | View |
| 2021-04-20 Conversion | 2021-04-22 7:53 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 1,500,000 | $0 | 750,000 (Direct) | View |
Ownership | 2021-04-15 08:56 am | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer | 0 | $0 | 750,000 (Direct) | View |